Strados Labs

Asthma affects 300 million people worldwide, causing a significant burden to patients and healthcare systems. Wheezing, a hallmark asthma symptom, indicates airway obstruction but is traditionally assessed subjectively and episodically through auscultation and patient self-reporting.

Our RESP® Biosensor is the first FDA-cleared device that continuously captures lung sounds including wheezing—providing clinicians and researchers with greater, more reliable data on treatment response and patient progress.

Features:

• Clinically validated: 510(k) cleared and equivalent to Littman 3200 stethoscope performance
• Passive monitoring: Captures lung sounds passively and continuously as a wearable device
• Patient-friendly: Wireless and unobtrusive with positive patient feedback

Learn more on our website: https://bit.ly/4fde0AR

This November, we're joining the COPD Foundation and its community for COPD Awareness Month!

Through initiatives like the Lace Up for Lungs challenge, the Foundation is raising awareness of chronic lung disease. With COPD among the top global causes of death, early diagnosis, support, and accessible treatment are essential.

COPD encompasses progressive lung conditions, including emphysema and chronic bronchitis, impacting millions worldwide, often undiagnosed. With prompt diagnosis and tailored treatment, those affected by COPD can experience improved quality of life.

Learn more: https://bit.ly/4eWq5dr

We’re thrilled to welcome two talented new members to the Strados Labs team!

Ozioma Orjioke (Ozi) - Firmware Engineer II
Ozi is a team-oriented, award-winning computer engineer with a specialization in embedded systems, low-level optimization, and IT. A 2020 Georgia Tech grad with 3 years of engineering experience, Ozi also brings a unique background in technical sales and media. He’s eager to dive into projects that make a real impact on patients' lives!

Kevyn Liang - Mechanical Engineer
Kevyn, originally from New York, has called Atlanta home since attending Georgia Tech. With over 5 years of experience designing complex products, he’s worked extensively in product development, parametric modeling, and prototype testing. Kevyn looks forward to contributing his expertise to Strados’ mission of improving patient care through engineering innovation!

We look forward to seeing the fresh perspectives Ozi and Kevyn will bring to our team. Welcome aboard!

Living with COPD can be challenging, but with the right tools and support, you can actively manage symptoms and improve your quality of life. The American Lung Association’s resource page offers essential advice on keeping your COPD under control, from recognizing flare-up signs, building an action plan, and adjusting your diet to incorporating safe physical activity. Each of these steps can empower you to feel more in control of your health. https://bit.ly/3YhxGwl

At Strados Labs, we’re focused on making life with COPD easier. Our RESP® Biosensor continuously monitors lung sounds like cough, wheeze, and crackles, helping patients and providers gain real-time insights into respiratory health at home. Early awareness of symptom changes and treatment responses can reduce hospitalizations and provide greater peace of mind.

Living with COPD With COPD, there are lifestyle changes that can help you stay more active and improve your quality of life. 

The 21st BioPharma Clinical Trials Nexus by Nexus Conference starts today! Our team including Nick Delmonico, Shane Krauss, and Devan Parson, MBA will connect with industry leaders on-site and share insights on the latest advancements in cough monitoring, clinical trials and digital health.

This is a fantastic opportunity to collaborate and explore innovative solutions that enhance patient-centricity in clinical research. If you're attending, please message us to connect!

We’re counting down to the Nexus Clinical Trial Conference sponsored by Nexus Conference on October 22-23 in Somerset, NJ! Our CEO, Nick Delmonico, will be moderating a session titled "The Role of Decentralized Clinical Trials and Digitalization: Bridging the Gap in Modern Clinical Research" on October 23rd from 11:40 am to 12:15 pm.

Join us to explore how digital innovations are transforming clinical trials and enhancing patient engagement. It’s an exciting opportunity to discuss the future of clinical operations!

Our recent blog, authored by Annotation Manager, Rachel Hollatz, dives deep into understanding lung sounds associated with COPD. These adventitious sounds, like wheezing and crackles, are vital indicators of airflow obstruction, lung fluid, and inflammation. The blog discusses how identifying these sounds can aid in diagnosis, treatment, and proactive management.

Rachel also highlights the limitations of traditional auscultation and the benefits of continuous monitoring through wearables, such as our RESP® Biosensor, offering more comprehensive insights into patient health beyond clinical visits.

Explore the blog for an in-depth look: https://stradoslabs.com/copd-lung-sounds-what-do-they-mean/

COPD Lung Sounds - What Do They Mean? COPD can lead to many lung sounds such as wheezing and crackles that might alarm patients. This article dives into the main COPD lung sounds.

We’re pleased to share insights from Dr. Henry Schmidt, MD, Principal Investigator of our recent pediatric asthma study in collaboration with Ann & Robert H. Lurie Children's Hospital of Chicago.

This study assessed the performance and usability of the RESP® Biosensor in children with asthma, a condition affecting over 5 million children annually and a leading cause of ED visits. Previously used only with adults, the RESP Biosensor shows significant potential in enhancing pediatric asthma management. Key findings revealed the biosensor's sensitivity in detecting wheezing, receiving overwhelmingly positive feedback from both patients and families. Participants valued its ease of use, expressing optimism for better at-home wheeze detection and access to care.

Dr. Schmidt highlights that continuous lung sound monitoring could greatly improve pediatric asthma care by providing clinicians with objective data at home and in the hospital. This technology allows for earlier assessments, paving the way for timely interventions and improved patient outcomes. Read the full interview here: https://bit.ly/480cQWx

October is National Healthy Lung Month, a reminder to prioritize lung health and raise awareness about protecting our lungs from neglect, bronchitis, mold, pollution, and smoking. If you experience a persistent cough, chest tightness, wheezing, or shortness of breath, especially during physical activity, don’t ignore these warning signs. They could indicate serious lung issues, and a doctor’s visit can help catch problems early.

Take advantage of community resources this October to manage lung conditions, quit smoking, and breathe easier. Learn more: https://bit.ly/4duh3Df

Our team will be attending the 21st BioPharma Clinical Trials Nexus Conference in just two weeks from October 22-23 in Somerset, NJ! https://lnkd.in/d8J_rmEN

The event gathers top clinical trial decision-makers and solution providers to address challenges and trends in clinical operations, patient-centricity, clinical outsourcing, and digital innovation. Nick Delmonico, Shane Krauss and Devan Parson, MBA are looking forward to connecting and engaging with life sciences and clinical trial leaders!

The Centers for Disease Control and Prevention (CDC)'s 2024-2025 respiratory virus season outlook predicts that peak hospitalizations for COVID-19, influenza, and RSV will likely be similar to or lower than last season, with an 80% probability. These insights highlight the need for continued monitoring and preventive measures.

At Strados Labs, we’re dedicated to advancing remote respiratory monitoring solutions that support patients and clinicians during this critical season. For more details on the CDC’s outlook, check out this overview from TechTarget News: https://bit.ly/3MZfjXz

Reviewing the CDC 2024-2025 respiratory virus season outlook | TechTarget The CDC's 2024-2025 respiratory virus season outlook predicts lower or similar hospitalization peaks to the 2023-2024 season rates.

The RESP® Biosensor was designed with both clinicians and patients in mind. Patients can easily apply the small, discreet device to their chest, sync it with an app, and start recording breath sounds with just a tap. This allows care teams to access lung sound data remotely, ensuring continuous monitoring without disrupting daily life. Its low-profile design enhances patient comfort and promotes adherence, capturing data in natural settings.

Hear from Devan Parson, MBA, our Clinical Operations Manager, on how she utilized RESP in a clinical trial for and patients: https://vimeo.com/668302345

A Clinical Researcher’s Perspective on the RESP® Biosensor This is "A Clinical Researcher’s Perspective on the RESP® Biosensor" by Strados Labs on Vimeo, the home for high quality videos and the people…

In honor of Pulmonary Fibrosis Awareness Month, we’re sharing the latest episode of the Medscape InDiscussion podcast on Idiopathic Pulmonary Fibrosis (IPF). The discussion delves into the role of patient advocacy in managing IPF, focusing on the profound impact of symptoms like breathlessness, cough, and fatigue. It also addresses how misinformation can worsen the challenges faced by patients, underscoring the critical role of advocacy groups in providing accurate, reliable information.

Our RESP® technology aids IPF patients by objectively monitoring cough and lung sounds, offering real-time insights into their respiratory health and helping detect changes that may require medical attention.

Listen to the full podcast to learn how patient advocacy is making a difference for those affected by IPF: https://bit.ly/3Me4KzL

S2 Episode 4: How Patient Advocacy Is Transforming IPF Research and Care Dr Jeffrey Swigris and Scott Staszak discuss how patient advocacy at the Pulmonary Fibrosis Foundation is transforming IPF care and research.

Patient self-reporting of cough provides valuable insights in clinical trials, but objective data can offer a deeper perspective. Discover highlights from our collaboration with Scripps Translational Research, where we compared patient-reported cough data with objective monitoring using the RESP® Biosensor. Watch Lead Software Developer Callum Gouveia Da Silva share the key findings: https://vimeo.com/842687498

Strados Labs Oral Abstract: 9th American Cough Conference 2023 This is "Strados Labs Oral Abstract: 9th American Cough Conference 2023" by Strados Labs on Vimeo, the home for high quality videos and the people who…

Our CEO and Co-Founder, Nick Delmonico, was recently featured in Respiratory Therapy Magazine! In this interview, Nick discusses our innovative RESP® Biosensor, a wearable device that continuously captures lung sounds like coughs and wheezes. This FDA-cleared technology enables clinicians to remotely monitor patients with chronic respiratory conditions such as COPD and asthma, offering valuable real-time data and potentially reducing the need for in-person visits.

Inspired by his own experience as an asthma patient, Nick developed the RESP® Biosensor to bridge gaps in monitoring and improve patient care. Clinical trials have shown promising results, demonstrating its effectiveness in preventing readmissions and enhancing management of respiratory conditions.

For more insights into how we’re transforming respiratory care, check out the full interview on page 64: https://bit.ly/3ZsLs1r

Our team had a great few days in Vienna at ERS. This year one of the main topics was the promise of digital health technologies, including cough monitoring technologies, in providing new and valuable insight into patients' lung health remotely.

We're excited to continue providing accurate, comprehensive insights into patients' cough and quality of life while also collecting lung sounds such as wheezing and crackles for a more complete picture.

Thank you European Respiratory Society for managing the event and all you do to improve respiratory care. We hope to participate next year!

The digitization of healthcare and the COVID-19 pandemic have revolutionized remote monitoring, particularly for patients with interstitial lung diseases (ILDs). Home monitoring can improve access to specialist care, enhance patient quality of life, and streamline clinical trials. This approach leverages devices like home spirometers, pulse oximeters, activity trackers, and cough monitors to provide critical health data.

While challenges such as technical reliability, financial barriers, and healthcare disparities remain, the potential benefits are significant. Read more in this article from Elsevier: https://bit.ly/4djiJzE

We’re excited about the advancements in home monitoring technologies like our end-to-end solution for remote monitoring of lung health, and the promise they hold for the future of ILD care and research.

We’re live at European Respiratory Society's ERS Congress in Vienna! Our CEO Nick Delmonico and Director of Strategy Shane Krauss are here, diving into the latest innovations in respiratory medicine and participating in insightful discussions on the role of AI in transforming patient care.

If you’re attending, don’t miss the opportunity to connect with us—we’re eager to collaborate and explore how we can advance respiratory health together. Message us or comment below to schedule a time to meet up.

September is Pulmonary Fibrosis Awareness Month! Pulmonary fibrosis ( ) involves scarring in the lungs, impacting oxygen flow. PF includes 200+ lung diseases, with idiopathic pulmonary fibrosis (IPF) being the most common, affecting ~100,000 in the U.S.

Join us in raising awareness and supporting those affected. Follow Pulmonary Fibrosis Foundation's 30 Facts In 30 Days series to learn more.

Happy Labor Day from Strados Labs! Today, we celebrate the hard work and dedication of all the incredible professionals who make our progress possible. Thank you for your tireless efforts and contributions!

Enjoy a well-deserved break!

ICYMI: We took home the top prize at the HealthTech Innovators Hackathon in the Remote Patient Monitoring and Real-World Data track! This win highlights our dedication to advancing patient care through innovative digital solutions. A big shoutout to Regeneron for hosting and to all the incredible participants. Check out the full list of winners here: https://regeneron.devpost.com/project-gallery

Health Tech Innovators Entrants should create digital, scalable solutions that improve patient care while also potentially accelerating clinical research.

Could undiagnosed asthma or COPD be impacting your health? Early diagnosis and treatment can lead to significantly better health outcomes, including fewer doctor visits and improved quality of life. A recent study published in the NEJM Group highlights that nearly 70% of people with these conditions are undiagnosed, missing out on critical care. If you’ve been experiencing persistent symptoms like shortness of breath or a lingering cough, it’s important to consult your physician and request a spirometry test. Learn more from Medical News Today: https://bit.ly/4dqbENS

Our RESP® Biosensor can provide greater diagnostic insight into patients' lung health by continuously capturing lung sounds like cough, wheeze, and crackles outside of a doctor's visit.

Asthma, COPD: Trial shows benefits of diagnosing conditions early Researchers say a clinical trial has shown how important it is to diagnose asthma and COPD early to provide effective treatments and improve a person's quality of life

Our CEO Nick Delmonico and Director of Strategy Shane Krauss will be traveling to Vienna, Austria to attend and exhibit at the ERS Congress from September 7-11! The congress gathers global respiratory experts to showcase the latest advancements in respiratory medicine and science. Nick and Shane are excited to connect with industry leaders, discuss innovations, and gain insights to advance our mission.

Visit us at our booth (B1.05) or schedule a meeting! https://meetings.hubspot.com/shane286/ers

Our team has arrived in Boston for the IPF Summit, ready to dive into the latest in pulmonary fibrosis therapeutics and connect with industry leaders.

Follow along for key insights, highlights, and updates from the event. We’re excited to drive the conversation on PF treatment!

Want to meet up at the summit? Message us or comment below!

The 8th IPF Summit is less than a week away! This year's summit will feature:
• Innovative Case Studies: Showcasing advancements in novel therapies and successful treatment strategies for IPF.
• Provocative Discussions: Debates on pressing issues, challenges, and controversies in pulmonary fibrosis.
• Forward-Thinking Sessions: Exploring combinatory approaches and precision medicine to tailor treatments.

Connect with our CEO Nick Delmonico and Director of Business Development Shane Krauss at the event in Boston, August 20-22. See you there!